Total Funding
41
Total FundingVenture - Series Unknown raised
Growth Score
pts
Heat Score
-18 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Gliatech Inc. (NASDAQ: GLIA) was founded in 1988 to discover, develop, and commercialize therapeutic products.
About the Company
Gliatech Inc. (NASDAQ: GLIA) was founded in 1988 to discover, develop, and commercialize therapeutic products based on the properties of glial cells. Glial cells perform key roles in the formation and function of the central nervous system (CNS). Gliatech has two separate development programs. The first is focused on the development of ADCON®
(adhesion control) gels and solutions, classified as medical devices, that inhibit the formation of postsurgical scarring and adhesions. The second program is based on the development of small molecule drug candidates for the treatment of specific CNS disorders such as Alzheimer's disease, Attention Deficit Hyperactive Disorder (ADHD), and narcolepsy.
